Cellular cryobiology – a review of basic concepts and “operating design” of cryopreserved cells
References
Armitage WJ. Metabolism and physiology of cells at low tem-peratures. In: Smit Sibinga CT, Das PC, Meryman HT, editors. Cryopreservation and low temperature biology in blood trans-fusion. Developments in Hematology and Immunology, vol 24. Boston, MA: Springer; 1990. p. 1–10.
Pegg DE. Principles of cryopreservation. Methods Mol Biol 2007; 368: 39–57.
Jang TH, Park SC, Yang JH, Kim JY, Seok JH, Park US, et al. Cryopreservation and its clinical applications. Integr Med Res 2017; 6(1): 12–8.
Meryman HT. Cryopreservation of living cells: principles and practice. Transfusion 2007; 47(5): 935–45.
Pavlovic M, Balint B. Stem Cells and Tissue Engineering. New York: Springer Science & Business Media; 2012. p. 154.
Polge C, Smith AU, Parkes AS. Revival of spermatozoa after vitrification and dehydration at low temperatures. Nature 1949; 164(4172): 666.
Lovelock JE, Bishop MW. Prevention of freezing damage to liv-ing cells by dimethyl sulfoxide. Nature 1959; 183(4672): 1394–5.
Meryman HT. Mechanics of freezing in living cells and tissues. Science 1956; 124(3221): 515–21.
Rowe AW, Rinfret AP. Controlled rate freezing of bone mar-row. Blood 1962; 20(5): 636.
Mazur P. Theoretical and experimental effects of cooling and warming velocity on the survival of frozen and thawed cells. Cryobiology 1966; 2(4): 181–92.
Whaley D, Damyar K, Witek RP, Mendoza A, Alexander M, Lakey JR. Cryopreservation: An overview of principles and cell-specific considerations. Cell Transplant 2021; 30: 963689721999617.
Uhrig M, Ezquer F, Ezquer M. Improving cell recovery: freezing and thawing optimization of induced pluripotent stem cells. Cells 2022; 11(5): 799.
Elliott GD, Wang S, Fuller BJ. Cryoprotectants: A review of the actions and applications of cryoprotective solutes that modulate cell recovery from ultra-low temperatures. Cryobiology 2017; 76: 74–91.
Balint B. Stem and progenitor cell harvesting, extracorporeal “graft engineering” and clinical use – initial expansion vs. cur-rent dilemmas. Clin Appl Immunol 2006; 5(1): 518–27.
Balint B, Ljubenov M, Stamatović D, Todorović M, Pavlović M, Ostojić G, et al. Stem cell harvesting protocol research in autologous transplantation setting: large volume vs. conventional cytapheresis. Vojnosanit Pregl 2008; 65(7): 545–51.
Balint B, Todorovic Balint M, Urosevic I, Pavlovic M. Stem cell transplant: from cell harvesting to cryopreservation. Med Pregl 2017; 70(Suppl 1): 41–5.
Balint B, Ivanovic Z, Petakov M, Taseski J, Jovicić G, Stojanović N, et al. The cryopreservation protocol optimal for progenitor re-covery is not optimal for preservation of marrow repopulating ability. Bone Marrow Transplant 1999; 23(6): 613–9.
Skoric D, Balint B, Petakov M, Sindjic M, Rodic P. Collection strategies and cryopreservation of umbilical cord blood. Trans-fus Med 2007; 17(2): 107–13.
Balint B, Vucetić D, Trajković-Lakić Z, Petakov M, Bugarski D, Brajusković G, et al. Quantitative, functional, morphological and ultrastructural recovery of platelets as predictor for cryopreservation. Haematologia (Budap) 2002; 32(4): 363–75.
Balint B, Paunovic D, Vucetic D, Vojvodic D, Petakov M, Trkuljic M, et al. Controlled-rate versus uncontrolled-rate freezing as predictors for platelet cryopreservation efficacy. Transfusion 2006; 46(2): 230–5.
Stolzing A, Naaldijk Y, Fedorova V, Sethe S. Hydroxyethylstarch in cryopreservation - mechanisms, benefits and problems. Transfus Apher Sci 2012; 46(2): 137–47.
Balint B, Stamatović D, Todorović M, Jevtić M, Ostojić G, Pavlović M, et al. Stem cells in the arrangement of bone marrow repopulation and regenerative medicine. Vojnosanit Pregl 2007; 64(7): 481–4.
Balint B, Pavlovic M, Todorovic M. Stem cells: Haemobiology and clinical data summarising: a critical review. Scr Med 2020; 51(4): 261–71.
Balint B, Pavlovic M, Todorovic M. From nucleated to ex vi-vo manipulated stem cells – an updated biological and clinical synopsis. Med Word 2020; 1(1): 1–8.
Balint B, Pavlovic M, Marković O, Borovic S, Todorovic M. A stem cell overview – from evolving hemobiological concepts to (au-to)grafting in clinical practice. Serb J Med Chamber 2022; 3(2): 135–48.
Balint B, Stanojevic I, Todorovic M, Stamatovic D, Pavlovic M, Voj-vodic D. Relative frequency of immature CD34+/CD90+ sub-set in peripheral blood following mobilization correlates close-ly and inversely with the absolute count of harvested stem cells in multiple myeloma patients. Vojnosanit Pregl 2017; 74(11): 1071–7.
Zeng G, Hu Y, Hu X, Zeng W, Liang X, Liu Y, et al. Cryopreservation of peripheral blood mononuclear cells us-ing uncontrolled rate freezing. Cell Tissue Bank 2020; 21(4): 631–41.
Setia RD, Arora S, Handoo A, Choudhary D, Sharma SK, Khandel-wal V, et al. Outcome of 51 autologous peripheral blood stem cell transplants after uncontrolled-rate freezing ("dump freez-ing") using -80°C mechanical freezer. Asian J Transfus Sci 2018; 12(2): 117–22. doi: 10.4103/ajts.AJTS_42_17
Halle P, Tournilhac O, Knopinska-Posluszny W, Kanold J, Gembara P, Boiret N, et al. Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5-percent DMSO in cryoprotective so-lution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001; 41(5): 667–73. doi: 10.1046/j.1537-2995.2001.41050667.x
Todorović-Balint M, Bila J, Balint B, Jeličić J, Djunić I, Antić D, et al. Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants. Vojnosanit Pregl 2020; 77(8): 844–51.
Abrahamsen JF, Bakken AM, Bruserud Ø. Cryopreserving human peripheral blood progenitor cells with 5-percent rather than 10-percent DMSO results in less apoptosis and necrosis in CD34+ cells. Transfusion 2002; 42(12): 1573–80.
Cai J, Weiss ML, Rao MS. In search of "stemness". Exp Hematol 2004; 32(7): 585–98.
Dianat-Moghadam H, Sharifi M, Salehi R, Keshavarz M, Shahgolzari M, Amoozgar Z. Engaging stemness improves cancer immunotherapy. Cancer Lett 2023; 554: 216007.
Al-Azab M, Idiiatullina E, Safi M, Hezam K. Enhancers of mes-enchymal stem cell stemness and therapeutic potency. Biomed Pharmacother 2023; 162: 114356.
Cai J, Chen H, Xie S, Hu Z, Bai Y. Research progress of totipotent stem cells. Stem Cells Dev 2022; 31(13–14): 335–45.
Liesveld JL, Sharma N, Aljitawi OS. Stem cell homing: From physiology to therapeutics. Stem Cells 2020; 38(10): 1241–53.
Quesenberry PJ, Wen S, Goldberg LR, Dooner MS. The universal stem cell. Leukemia 2022; 36(12): 2784–92.
Slack JMW. What is a stem cell? Wiley Interdiscip Rev Dev Biol 2018; 7(5): e323.
Samperio Ventayol P, Bartfeld S. Immune cell-stem cell interac-tions in regeneration and repair: who's calling the shots? De-velopment 2022; 149(8): dev200228.
Rudolph KL. Stem cell aging. Mech Ageing Dev 2021; 193: 111394.
Lee DA, Knight MM, Campbell JJ, Bader DL. Stem cell mecha-nobiology. J Cell Biochem 2011; 112(1): 1–9.
Chen X, Tang K, Li X, Zhang C, Xin Y, Li K, et al. Biomechan-ics of cancer stem cells. Essays Biochem 2022; 66(4): 359–69.
Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, et al. Stem cell-based therapy for human diseases. Signal Transduct Target Ther 2022; 7(1): 272.